Literature DB >> 25823224

Phospholipid remodeling and eicosanoid signaling in colon cancer cells.

Siddhartha Das, Leobarda Robles Martinez, Suparna Ray.   

Abstract

Phospholipid remodeling and eicosanoid synthesis are central to lipid-based inflammatory reactions. Studies have revealed that membrane phospholipid remodeling by fatty acids through deacylation/reacylation reactions increases the risk of colorectal cancers (CRC) by allowing the cells to produce excess inflammatory eicosanoids, such as prostaglandins, thromboxanes and leukotrienes. Over the years, efforts have been made to understand the lipid remodeling pathways and to design anti-cancer drugs targeting the enzymes of eicosanoid biosynthesis. Here, we discuss the recent progress in phospholipid remodeling and eicosanoid biosynthesis in CRC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25823224      PMCID: PMC4460191     

Source DB:  PubMed          Journal:  Indian J Biochem Biophys        ISSN: 0301-1208            Impact factor:   1.918


  57 in total

1.  On the TREATMENT of GLYCOSURIA and DIABETES MELLITUS with ASPIRIN.

Authors:  R T Williamson
Journal:  Br Med J       Date:  1902-12-27

2.  HT-29 human colon cancer cell proliferation is regulated by cytosolic phospholipase A(2)α dependent PGE(2)via both PKA and PKB pathways.

Authors:  Liz Kisslov; Nurit Hadad; Marina Rosengraten; Rachel Levy
Journal:  Biochim Biophys Acta       Date:  2012-06-19

Review 3.  Leukotrienes.

Authors:  Marc Peters-Golden; William R Henderson
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

4.  Aspirin and pancreatic cancer pain.

Authors:  C G Moertel; D L Ahmann; W F Taylor; N Schwartau
Journal:  Gastroenterology       Date:  1971-04       Impact factor: 22.682

5.  Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.

Authors:  T O Daniel; H Liu; J D Morrow; B C Crews; L J Marnett
Journal:  Cancer Res       Date:  1999-09-15       Impact factor: 12.701

Review 6.  The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia.

Authors:  Basil Rigas
Journal:  Curr Opin Gastroenterol       Date:  2007-01       Impact factor: 3.287

7.  Resistance to apoptosis is increased during metastatic dissemination of colon cancer.

Authors:  L Oliver; S Cordel; I Barbieux; M T LeCabellec; K Meflah; M Grégoire; F M Vallette
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

8.  Mitochondrial localization of cyclooxygenase-2 and calcium-independent phospholipase A2 in human cancer cells: implication in apoptosis resistance.

Authors:  Jun-Yang Liou; Nena Aleksic; Shu-Fen Chen; Tsai-Jung Han; Song-Kun Shyue; Kenneth K Wu
Journal:  Exp Cell Res       Date:  2005-03-16       Impact factor: 3.905

9.  Leukotriene D4 mediates survival and proliferation via separate but parallel pathways in the human intestinal epithelial cell line Int 407.

Authors:  Sailaja Paruchuri; Anita Sjölander
Journal:  J Biol Chem       Date:  2003-08-11       Impact factor: 5.157

10.  Deficiency of phospholipase A2 group 7 decreases intestinal polyposis and colon tumorigenesis in Apc(Min/+) mice.

Authors:  Changxin Xu; Ethan C Reichert; Tomoyuki Nakano; Mariah Lohse; Alison A Gardner; Mónica P Revelo; Matthew K Topham; Diana M Stafforini
Journal:  Cancer Res       Date:  2013-01-29       Impact factor: 12.701

View more
  4 in total

1.  Fecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer.

Authors:  Eun Mi Song; Jeong-Sik Byeon; Sun Mi Lee; Hyun Ju Yoo; Su Jung Kim; Sun-Ho Lee; Kiju Chang; Sung Wook Hwang; Dong-Hoon Yang; Jin-Yong Jeong
Journal:  Dig Dis Sci       Date:  2018-03-07       Impact factor: 3.199

2.  Altered Saturated and Monounsaturated Plasma Phospholipid Fatty Acid Profiles in Adult Males with Colon Adenomas.

Authors:  C Austin Pickens; Ami Lane-Elliot; Sarah S Comstock; Jenifer I Fenton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-31       Impact factor: 4.254

3.  Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1α-modulated fatty acid metabolism.

Authors:  Ting Ni; Zihao He; Yuanyuan Dai; Jingyue Yao; Qinglong Guo; Libin Wei
Journal:  Cell Death Dis       Date:  2017-06-08       Impact factor: 8.469

4.  Arachidonic Acid Induces the Migration of MDA-MB-231 Cells by Activating Raft-associated Leukotriene B4 Receptors.

Authors:  Atasi De Chatterjee; Debarshi Roy; Priscilla Guevara; Rituraj Pal; Mahesh Naryan; Sukla Roychowdhury; Siddhartha Das
Journal:  Clin Cancer Drugs       Date:  2018
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.